Susquehanna International Group’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $199K | Buy |
270,776
+88,435
| +48% | +$64.8K | ﹤0.01% | 5550 |
|
|
2025
Q1 | $182K | Buy |
182,341
+146,060
| +403% | +$146K | ﹤0.01% | 5572 |
|
|
2024
Q4 | $385K | Sell |
36,281
-7,371
| -17% | -$78.1K | ﹤0.01% | 4435 |
|
|
2024
Q3 | $577K | Sell |
43,652
-9,598
| -18% | -$127K | ﹤0.01% | 3453 |
|
|
2024
Q2 | $523K | Buy |
53,250
+41,859
| +367% | +$411K | ﹤0.01% | 3456 |
|
|
2024
Q1 | $157K | Buy |
11,391
+64
| +0.6% | +$880 | ﹤0.01% | 4810 |
|
|
2023
Q4 | $193K | Sell |
11,327
-17,507
| -61% | -$298K | ﹤0.01% | 5032 |
|
|
2023
Q3 | $407K | Buy |
+28,834
| New | +$407K | ﹤0.01% | 3688 |
|